Workflow
PTC(PTC)
icon
Search documents
PTC(PTC) - 2024 Q4 - Earnings Call Transcript
2024-11-07 03:18
Financial Data and Key Metrics Changes - In fiscal 2024, free cash flow grew by 25% year-over-year, reaching $736 million [8][34] - Constant currency ARR increased by 12% year-over-year, totaling $2.207 billion at the end of Q4 [8][33] - Operating efficiency improved by 370 basis points to 42% compared to 38% in fiscal 2023 [34] Business Line Data and Key Metrics Changes - In Q4, constant currency ARR growth was 10% in CAD and 13% in PLM, indicating strong performance in these segments [41] - The company reported solid results in areas like APAC and its reseller channel, while Western Europe showed relative weakness [9][41] Market Data and Key Metrics Changes - Organic constant currency ARR growth was solid across the Americas, Europe, and APAC, with growth rates in the low to mid-double digits [42] - The automotive sector in Western Europe is under pressure, affecting deal sizes and timelines, but there is a push for digital transformation [89][90] Company Strategy and Development Direction - The company is focusing on five key areas: PLM (Windchill), ALM (Codebeamer), SLM (ServiceMax), CAD (Creo), and SaaS [11][12] - A new Chief Revenue Officer will be hired to enhance focus and accountability in a vertically oriented go-to-market model [19][21] - The go-to-market structure is being realigned around key verticals to improve specialization and effectiveness [20][22] Management's Comments on Operating Environment and Future Outlook - Management acknowledges macroeconomic headwinds and geopolitical uncertainty but remains confident in the long-term trajectory due to a shift in key verticals [9][10] - There is a strong demand for digital transformation among customers, which the company's offerings are well-positioned to address [12][15] Other Important Information - A $2 billion share repurchase authorization was announced, reflecting confidence in the business and commitment to enhancing shareholder value [10][45] - The company expects free cash flow to grow faster than ARR over the medium term, with operating expenses growing at roughly half the rate of ARR [34][35] Q&A Session Summary Question: Go-to-market disruption and growth rates - Management is not expecting significant disruption from the go-to-market changes and has mechanisms in place to minimize any potential impact [78][79] Question: Market performance and product focus - Strong performance is expected in PLM and CAD, with a focus on expanding Windchill and Codebeamer in key verticals [82][84] Question: Demand in Western Europe - There is pressure in the automotive sector, but this is driving urgency for digital transformation, which could benefit the company [88][90] Question: Timing of go-to-market changes and potential demand recovery - The company is prepared for potential demand increases and is aligning its operations to capitalize on opportunities as they arise [92][94] Question: Performance across other verticals - The federal, aerospace, and defense sectors are experiencing significant demand, while med tech and life sciences are also seeing a need for faster product development [99][100]
PTC(PTC) - 2024 Q4 - Earnings Call Presentation
2024-11-06 23:55
Q4'24 AND FY'24 FINANCIAL RESULTS Neil Barua CEO Kristian Talvitie CFO November 6, 2024 FORWARD LOOKING STATEMENTS 2 This presentation includes forward looking statements regarding PTC's future financial performance, strategic outlook and expectations, anticipated future operations, expected effects of strategic investments and initiatives, and share repurchase expectations. Because such statements deal with future events, actual results may differ materially from those projected in the forward-looking stat ...
PTC Inc. (PTC) Q4 Earnings and Revenues Beat Estimates
ZACKS· 2024-11-06 23:21
PTC Inc. (PTC) came out with quarterly earnings of $1.54 per share, beating the Zacks Consensus Estimate of $1.43 per share. This compares to earnings of $1.20 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 7.69%. A quarter ago, it was expected that this product development software maker would post earnings of $0.98 per share when it actually produced earnings of $0.98, delivering no surprise.Over the last four quarters, the ...
PTC ANNOUNCES $2 BILLION SHARE REPURCHASE AUTHORIZATION
Prnewswire· 2024-11-06 21:01
BOSTON, Nov. 6, 2024 /PRNewswire/ -- PTC (NASDAQ: PTC) today announced that its Board of Directors has authorized the repurchase of up to $2 billion worth of PTC common stock through September 30, 2027."This repurchase authorization demonstrates the Board's confidence in PTC's ability to drive customer value while enhancing shareholder returns, and supports PTC's capital allocation strategy," said Janice Chaffin, Chair of the Board."PTC intends to repurchase approximately $300 million of our common stock in ...
PTC ANNOUNCES FOURTH FISCAL QUARTER AND FULL FISCAL YEAR 2024 RESULTS
Prnewswire· 2024-11-06 21:01
Solid ARR and Cash Flow in Fourth Fiscal Quarter and Full Fiscal YearBOSTON, Nov. 6, 2024 /PRNewswire/ -- PTC (NASDAQ: PTC) today reported financial results for its fourth fiscal quarter and full fiscal year ended September 30, 2024."In fiscal year 2024, we again delivered solid ARR and cash flow, with year-over-year ARR growth in the low double-digits and cash flow growth above 20%. We have a differentiated strategy that leverages our unique portfolio to help product companies accelerate their time to mark ...
PTC(PTC) - 2024 Q4 - Annual Results
2024-11-06 21:00
EX 99.1 PTC ANNOUNCES FOURTH FISCAL QUARTER AND FULL FISCAL YEAR 2024 RESULTS Solid ARR and Cash Flow in Fourth Fiscal Quarter and Full Fiscal Year BOSTON, MA, November 6, 2024 - PTC (NASDAQ: PTC) today reported financial results for its fourth fiscal quarter and full fiscal year ended September 30, 2024. "In fiscal year 2024, we again delivered solid ARR and cash flow, with year-over-year ARR growth in the low double-digits and cash flow growth above 20%. We have a differentiated strategy that leverages ou ...
PTC Inc. (PTC) Q4 Earnings Preview: What You Should Know Beyond the Headline Estimates
ZACKS· 2024-11-01 14:20
Wall Street analysts forecast that PTC Inc. (PTC) will report quarterly earnings of $1.43 per share in its upcoming release, pointing to a year-over-year increase of 19.2%. It is anticipated that revenues will amount to $620.49 million, exhibiting an increase of 13.5% compared to the year-ago quarter.The consensus EPS estimate for the quarter has undergone a downward revision of 1.1% in the past 30 days, bringing it to its present level. This represents how the covering analysts, as a whole, have reassessed ...
PTC Inc. (PTC) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
ZACKS· 2024-10-30 15:07
Wall Street expects a year-over-year increase in earnings on higher revenues when PTC Inc. (PTC) reports results for the quarter ended September 2024. While this widely-known consensus outlook is important in gauging the company's earnings picture, a powerful factor that could impact its near-term stock price is how the actual results compare to these estimates. The earnings report, which is expected to be released on November 6, 2024, might help the stock move higher if these key numbers are better than ex ...
Vishay Intertechnology High Energy Inrush Current Limiting PTC Thermistors Increase Performance in Active Charge and Discharge Circuits
GlobeNewswire News Room· 2024-10-30 15:00
MALVERN, Pa., Oct. 30, 2024 (GLOBE NEWSWIRE) -- Vishay Intertechnology, Inc. (NYSE: VSH) today introduced a new series of inrush current limiting positive temperature coefficient (PTC) thermistors. Designed to increase performance in active charge and discharge circuits for automotive and industrial applications, Vishay BCcomponents PTCEL High Energy series devices combine maximum energy handling to 340 J — five times higher than competing devices at high ambient temperatures — with a wide range of resistan ...
PTC Therapeutics Announces FDA Acceptance of Translarna™ NDA Resubmission
Prnewswire· 2024-10-30 11:00
WARREN, N.J., Oct. 30, 2024 /PRNewswire/ -- PTC Therapeutics, Inc. (NASDAQ: PTCT) announced today the U.S. Food and Drug Administration (FDA) has accepted for review the resubmission of the New Drug Application (NDA) for Translarna™ (ataluren) for the treatment of nonsense mutation Duchenne muscular dystrophy (nmDMD). "The NDA acceptance for review is a significant milestone that brings us one step closer to providing this important treatment to boys and young men living with nonsense mutation Duchenne musc ...